Thursday, April 22, 2021
Breking News
- Radio City & Mid-Day End the Season 2 of the Most Credible Hitlist OTT Awards With a Bang!
- Biocon Biologics and Viatris Inc. Receive CHMP Nod for Abevmy® , a Biosimilar to Avastin® (Bevacizumab)
- Reliance break another deal, Mubadala to invest ₹ 6,247.5 crore (AED 3.1 billion) in Reliance Retail Ventures".
- ITI Limited signs contract with Defense to implement Rs 7796 Crore ASCON Phase-IV project
- ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19TM
